|
The Development, Uses and Future of Gerovital H3
Introduction |
From the Past to the Present |
The Nature of Gerovital H3
Research and Speculation on Possible Benefits |
Some Additional Clinical Considerations
An Intangible Field of Resistance |
The Future of Gerovital H3 |
Footnotes |
Bibliography
THE FUTURE OF GEROVITAL H3
Despite research and results from around the world, Gerovital H3
marks only a beginning. Dr. Aslan herself realizes this and does not rest on her reputation. She is a product of her
own pioneering research. At age 85, she has the appearance of a woman several decades younger. She continues to work
up to 90 hours a week in patient care, traveling and lecturing. She reportedly is developing numerous other products
designed for preventative health care and the control of aging symptoms.
There is a widespread but incorrect notion that modern medicine is proceeding toward
wiping out the most serious illnesses. In fact, catastrophic diseases, notably cancer and heart failure, increase
steadily. This development is taking place as America expands the technology in most other fields by leaps and bounds.
Exact reasons for this decline in health are difficult to determine. Certainly, the United States has fallen behind in
the prevention of degenerative conditions.
With the widening acceptance of Gerovital H3 and other nutrients, preventive medicine
should emerge as an important aspect of health maintenance. As this moment proceeds, good information, makes the best
defense against manipulation. It also helps ensure true freedom of choice in health care.
< previous | next >
|